PRO CLAIMS IN ORPHAN MEDICINES APPROVED BY THE EUROPEAN MEDICINES AGENCY (EMA) FOR THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS
Author(s)
Acquadro C1, Perret C2, Arnould B3
1Mapi Research Trust, Lyon, France, 2MAPI Research Trust, Lyon, France, 3Mapi, Lyon, France
OBJECTIVES METHODS RESULTS
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PSY84
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Systemic Disorders/Conditions